New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 20, 2014
08:07 EDTLJPCLa Jolla Pharmaceutical receives notice of allowance for patent
La Jolla Pharmaceutical Company announced that the United States Patent and Trademark Office has issued a notice of allowance for patent application number 13/888,158 covering methods of treating chronic inflammation using modified pectin. Specifically, the patent, which expires in 2025 without taking into account patent term extension, provides proprietary protection for methods of treating chronic inflammation by administration of modified pectin with a molecular weight greater than 25 kilodaltons.
News For LJPC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 12, 2014
18:29 EDTLJPCOn The Fly: After Hours Movers
Subscribe for More Information
16:18 EDTLJPCLa Jolla reports GCS-100 Phase 2 study met primary endpoint
Subscribe for More Information
16:04 EDTLJPCLa Jolla reports Q3 EPS (37c), consensus (31c)
Subscribe for More Information
November 10, 2014
15:54 EDTLJPCAmerican Society of Nephrology to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use